Sifting through countless of stocks in the Health Care Equipment & Supplies industry can be tedious, and sometimes two stocks are just too similar to judge which is the better investment. If you’re on the fence about investing in Merit Medical Systems, Inc. or Establishment Labs Holdings Inc. because you’re not sure how they measure up, it’s important to compare them on a few factors before making your decision.

Read on to learn how Merit Medical Systems, Inc. and Establishment Labs Holdings Inc. compare based on key financial metrics to determine which better meets your investment needs.

About Merit Medical Systems, Inc. and Establishment Labs Holdings Inc.

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. It also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate structures; gastroenterology products, such as covered esophageal stents, syringe and gauges, and balloon dilators; and kits and accessories for endoscopy and bronchoscopy procedures, as well as non-pharmacological treatment of gastroesophageal reflux disease. It sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers. The company was incorporated in 1987 and is headquartered in South Jordan, Utah.

Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgeries. The company offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides breast tissue expanders. The company sells products to physicians, hospitals, and clinics through distributors and its direct sales force in Europe, the Middle East, Africa, Latin America, the Asia-Pacific, and North America. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.

Latest Health Care Equipment & Supplies and Merit Medical Systems, Inc., Establishment Labs Holdings Inc. Stock News

As of November 28, 2025, Merit Medical Systems, Inc. had a $5.1 billion market capitalization, compared to the Health Care Equipment & Supplies median of $305.8 million. Merit Medical Systems, Inc.’s stock is NA in 2025, NA in the previous five trading days and down 17.44% in the past year.

Currently, Merit Medical Systems, Inc.’s price-earnings ratio is 44.4. Merit Medical Systems, Inc.’s trailing 12-month revenue is $1.5 billion with a 8.0% net profit margin. Year-over-year quarterly sales growth most recently was 13.1%. Analysts expect adjusted earnings to reach $3.725 per share for the current fiscal year. Merit Medical Systems, Inc. does not currently pay a dividend.

Currently, Establishment Labs Holdings Inc. does not have a price-earnings ratio. Establishment Labs Holdings Inc.’s trailing 12-month revenue is $191.0 million with a -43.5% net profit margin. Year-over-year quarterly sales growth most recently was 33.8%. Analysts expect adjusted earnings to reach $-1.840 per share for the current fiscal year. Establishment Labs Holdings Inc. does not currently pay a dividend.

How We Compare Merit Medical Systems, Inc. and Establishment Labs Holdings Inc. Stock Grades

Stock evaluation requires access to huge amounts of data and the knowledge and time to sift through it all, make sense of financial ratios, read income statements and analyze recent stock movements. AAII created A+ Investor, a robust data suite that condenses data research in an actionable and customizable way suitable for investors of all knowledge levels, to help investors streamline and work through such data.

AAII’s proprietary stock grades come with A+ Investor. These offer intuitive A‐F grades for each of five key investing factors: value, growth, momentum, earnings estimate revisions and quality. Here, we’ll take a closer look at Merit Medical Systems, Inc. and Establishment Labs Holdings Inc.’s stock grades to see how they measure up against one another.

Learn more about A+ Investor here!

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

Merit Medical Systems, Inc. and Establishment Labs Holdings Inc. Stock Value Grades

Company	Ticker	Value
Merit Medical Systems, Inc.	MMSI	F
Establishment Labs Holdings Inc.	ESTA	F

Successful stock investing involves buying low and selling high, so stock valuation is an important consideration for stock selection.

Buying stocks that are going to go up typically means buying stocks that are undervalued in the first place, although momentum investors may argue that point.

AAII’s A+ Investor Value Grade derives from a stock’s value score. The Value Score is the percentile rank of the average of the percentile ranks of the price-to-sales ratio, price-earnings ratio, enterprise-value-to-EBITDA (EV/EBITDA) ratio, shareholder yield, price-to-book-value ratio and price-to-free-cash-flow ratio. The score is variable, meaning it can consider all six ratios or, should any of the six ratios not be valid, the remaining ratios that are valid. To be assigned a Value Score, stocks must have a valid (non-null) ratio and corresponding ranking for at least two of the six valuation ratios.

Stocks with a Value Score from 81 to 100 are considered deep value, those with a score between 61 and 80 are a good value and so on.

Merit Medical Systems, Inc. has a Value Score of 19, which is Ultra Expensive. Establishment Labs Holdings Inc. has a Value Score of 4, which is Ultra Expensive.

The Value Stock Winner: No Clear Winner

Neither Merit Medical Systems, Inc. or Establishment Labs Holdings Inc. has a high enough value grade to be considered a “winner.” Investors who are considering these companies should do additional due diligence and research to see if either could be a good addition to their portfolio. It’s important to look at a wide range of financial metrics in order to determine if Merit Medical Systems, Inc. or Establishment Labs Holdings Inc. is the better investment when it comes to value.

Merit Medical Systems, Inc. and Establishment Labs Holdings Inc. Growth Grades

Company	Ticker	Growth
Merit Medical Systems, Inc.	MMSI	A
Establishment Labs Holdings Inc.	ESTA	D

The foundation of growth investing is seeking out stocks of companies exhibiting strong, consistent and prolonged growth that is expected to continue into the future.

In order to compute the growth score and assign it a letter grade, the percentile ranks for each of three components‐consistency of annual sales growth, five-year sales growth rankings adjusted for extreme levels, and consistency of positive annual cash from operations‐must be determined. These three rank figures are added together, and the sum is ranked against the entire stock universe to arrive at a company’s Growth Score to create an equal distribution of grades.

The companies in the bottom 20% of the stock universe receive Growth Grades of F, considered to be very weak, while those in the top 20% receive A grades, which are considered very strong.

Merit Medical Systems, Inc. has a Growth Score of 97, which is Very Strong. Establishment Labs Holdings Inc. has a Growth Score of 40, which is Weak.

The Growth Grade Winner: Merit Medical Systems, Inc.

As you can clearly see from the Growth Grade breakdown above, Merit Medical Systems, Inc. has a more attractive growth grade than Establishment Labs Holdings Inc.. For investors who focus solely on how a company is growing relative to other companies in the same industry, Merit Medical Systems, Inc. could be a good stock to add to their portfolio. However, it’s important for investors to analyze multiple factors based on a wide range of metrics before deciding whether to buy.

Merit Medical Systems, Inc. and Establishment Labs Holdings Inc.’s Estimate Revisions Grades

Company	Ticker	Earnings Estimate
Merit Medical Systems, Inc.	MMSI	B
Establishment Labs Holdings Inc.	ESTA	B

Earnings estimate revisions scores consider the magnitude of a company’s earnings surprise in its last two reported fiscal quarters. Often, positive surprises beget further positive surprises‐or at least continued sales growth (the exact opposite is generally true, too).

Estimate revisions offer an indication of what analysts are thinking about the short-term prospects of a firm. Estimate revisions are based on the statistical significance of a firm’s last two quarterly earnings surprises and the percentage change in its consensus estimate for the current fiscal year over the past month and past three months.

Merit Medical Systems, Inc. has a Earnings Estimate Score of 77, which is Positive. Establishment Labs Holdings Inc. has a Earnings Estimate Score of 75, which is Positive.

The Earnings Estimate Revisions Grade Winner: It’s a Tie!

Looking at the Earnings Estimate Revisions Grade breakdown above, both Merit Medical Systems, Inc. and Establishment Labs Holdings Inc. have a grade of B. For those focusing solely on a company’s estimate revisions, other financial metrics will need to be evaluated to determine whether Merit Medical Systems, Inc. or Establishment Labs Holdings Inc. is a better fit.

Other Merit Medical Systems, Inc. and Establishment Labs Holdings Inc. Grades

In addition to Estimate Revisions, Value and Growth, A+ Investor also provides grades for Momentum and Quality.

Momentum grades help uncover stocks experiencing anomalously high rates of return; research finds that stocks with high relative levels of momentum tend to outperform, whereas those with low levels of momentum tend to continue underperforming.

AAII’s A+ Investor Quality Grade comes from the ranking of key metrics. Specifically, the quality grade is the percentile rank of the composite of return on assets (ROA), return on invested capital (ROIC), gross profit relative to assets, buyback yield, change in total liabilities to assets, accruals, Z double prime bankruptcy risk (Z) score and F-Score.

These 2 key factors, when combined with the above, provide a holistic view into a particular stock. Further, by joining A+ Investor you can see whether Merit Medical Systems, Inc. and Establishment Labs Holdings Inc. pass any of our 60+ stock screens that have outperformed the market since their creation.

So, Which Is the Better Investment, Merit Medical Systems, Inc. or Establishment Labs Holdings Inc. Stock?

Overall, Merit Medical Systems, Inc. stock has a Value Score of 19, Growth Score of 97 and Estimate Revisions Score of 77.

Establishment Labs Holdings Inc. stock has a Value Score of 4, Growth Score of 40 and Estimate Revisions Score of 75.

Comparing Merit Medical Systems, Inc. and Establishment Labs Holdings Inc.’s grades, scores and metrics can act as a solid basis to determine whether they may be a good investment or not. You’ll also want to look at your portfolio’s asset allocation as well as your risk tolerance and financial goals to see if either of these stocks would make a good fit for you. AAII can help you figure out which investments align with your individual needs and preferences.

Investors are encouraged to do their own due diligence and research. In this way, individuals can effectively become managers of their own assets‐without having to rely on others for financial independence. You can count on AAII for timeless articles on financial planning and stock-picking, unbiased research and actionable analysis.

A+ Investor adds to our qualitative teaching with a powerful data suite to help you whittle down investment choices to find stocks, exchange-traded funds (ETFs) or mutual funds that meet your needs.

AAII Disclaimer

We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown, because past, hypothetical or simulated performance is not necessarily indicative of future results. Before making an investment decision, you should consider your circumstances and whether the information on our content is applicable to your situation. This information was prepared in good faith, and we accept no liability for any errors or omissions. The full disclaimer can be read here.